ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 32 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $186,000 | -47.2% | 40,661 | 0.0% | 0.03% | -41.8% |
Q1 2022 | $352,000 | -52.6% | 40,661 | -21.8% | 0.06% | -52.6% |
Q4 2021 | $743,000 | -28.1% | 52,004 | +10.6% | 0.12% | -34.5% |
Q3 2021 | $1,033,000 | +411.4% | 47,004 | +212.1% | 0.18% | +405.7% |
Q2 2021 | $202,000 | +32.0% | 15,061 | 0.0% | 0.04% | +20.7% |
Q1 2021 | $153,000 | +139.1% | 15,061 | 0.0% | 0.03% | +123.1% |
Q4 2020 | $64,000 | +64.1% | 15,061 | 0.0% | 0.01% | +44.4% |
Q3 2020 | $39,000 | -26.4% | 15,061 | 0.0% | 0.01% | -40.0% |
Q2 2020 | $53,000 | +15.2% | 15,061 | 0.0% | 0.02% | -6.2% |
Q1 2020 | $46,000 | -41.0% | 15,061 | 0.0% | 0.02% | -33.3% |
Q4 2019 | $78,000 | +62.5% | 15,061 | 0.0% | 0.02% | +50.0% |
Q3 2019 | $48,000 | -11.1% | 15,061 | 0.0% | 0.02% | -15.8% |
Q2 2019 | $54,000 | -1.8% | 15,061 | 0.0% | 0.02% | -5.0% |
Q1 2019 | $55,000 | +22.2% | 15,061 | 0.0% | 0.02% | +5.3% |
Q4 2018 | $45,000 | -38.4% | 15,061 | 0.0% | 0.02% | -34.5% |
Q3 2018 | $73,000 | -34.8% | 15,061 | 0.0% | 0.03% | -59.7% |
Q2 2018 | $112,000 | +14.3% | 15,061 | 0.0% | 0.07% | -27.3% |
Q1 2018 | $98,000 | -99.9% | 15,061 | 0.0% | 0.10% | -27.7% |
Q4 2017 | $135,549,000 | – | 15,061 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MORGAN JESS S & CO INC | 576,317 | $1,504,000 | 1.50% |
Phoenix Holdings Ltd. | 197,763 | $483,000 | 0.02% |
Frontier Wealth Management LLC | 71,900 | $188,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 19,659 | $51,000 | 0.01% |
Rossmore Private Capital | 15,061 | $39,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 98,486 | $255,000 | 0.01% |
Virtu Financial LLC | 10,450 | $27,000 | 0.01% |
BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $15,000 | 0.01% |
Sterling Investment Advisors, Ltd. | 3,150 | $8,000 | 0.00% |
Qube Research & Technologies Ltd | 75,395 | $197,000 | 0.00% |